Echocardiographic evaluation of the effects of a single bolus of erythropoietin on reducing ischemia-reperfusion injuries during coronary artery bypass graft surgery; a randomized, double-blind, placebo-control study
IJMS-Iranian Journal of Medical Sciences. 2014; 39 (2): 94-101
Dans Anglais
| IMEMR
| ID: emr-177197
ABSTRACT
Background:
Erythropoietin [EPO] is known as a regulating hormone for the production of red blood cells, called erythropoiesis. Some studies have shown that EPO exerts some non-hematopoietic protective effects on ischemia-reperfusion injuries in myocytes. Using echocardiography, we evaluated the effect of EPO infusion on reducing ischemia-reperfusion injuries and improvement of the cardiac function shortly after coronary artery bypass graft surgery [CABG]
Recherche sur Google
Indice:
Méditerranée orientale
langue:
Anglais
Texte intégral:
Iran. J. Med. Sci.
Année:
2014
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS